Skip to main content
  • 27 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Allgemeine Literatur

  • Breitenecker G, Lax S. Tumoren des Corpus uteri, in: Holzner JH et al. (ed.) Histologische Tumorklassifikation der Österreichischen Gesellschaft für Pathologie Springer Verlag 1994

    Google Scholar 

  • Burghardt, E: Surgical Gynecologic Oncology Thieme Verlag 1993

    Google Scholar 

  • Gompel C, Silverberg St G. Pathology in Gynecology and Obstetrics. 4th edition. Chapter 4, The Corpus Uteri pp 163–284. J B Lippincott Company, Philadelphia, 1994

    Google Scholar 

  • Kurman RJ (editor) Blaustein’s Pathology of the Female Genital Tract. 4th edition Springer Verlag 1994

    Google Scholar 

  • Talerman A. Ovarian Pathology. Current Opinion in Obstetrics and Gynecology 4: 608–615, 1992

    Article  PubMed  CAS  Google Scholar 

  • TNM Klassifikation maligner Tumoren. 5th Auflage, Springer Verlag

    Google Scholar 

  • Wittekind CH, Wagner G. TNM Klassifikation maligner Tumoren. 5. Auflage 1997, Springer Verlag

    Google Scholar 

Originalarbeiten

  • Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Cancer (1988), 62: 2212–2222

    Article  PubMed  CAS  Google Scholar 

  • Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion. A report of 21 cases. Hum Pathol (1990), 21: 397–403

    Article  PubMed  CAS  Google Scholar 

  • Breitenecker G, Bartl W, Endler Margit, Gring H. Die prognostische Bedeutung morphologischer Parameter bei Endometriumkarzinomen. Onkologie (1984), 7: 222–235

    Article  PubMed  CAS  Google Scholar 

  • Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low grade carcinoma related to serous borderline tumors. Am J Surg Pathol (1996), 20: 1319–1330

    Article  PubMed  CAS  Google Scholar 

  • Casagrande ST, Pike MC, Ross RK et al. “Incessant ovulation” and ovarian cancer. Lancet (1979), 2:170

    Article  PubMed  CAS  Google Scholar 

  • Cramer DW et al. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med (1982), 307:1047

    Article  PubMed  CAS  Google Scholar 

  • Cramer DW et al. Mumps, menarche, menopause and ovarian cancer. Am J Obstet Gynecol (1983), 147: 1

    PubMed  CAS  Google Scholar 

  • Cramer DW et al. Dietary animal fat in relation to ovarian cancer risk. Obstet Gynecol (1984), 63: 883

    Google Scholar 

  • Harlow BL, Fuhr JE, McDonald ThW et al. Flow Cytometry as a Prognostic Indicator in Women with Borderline Epithelial Ovarian Tumors. Gynecologic Oncology (1993), 50: 305–309

    Article  PubMed  CAS  Google Scholar 

  • Henderson BE, Pike MC, Ross RK et al. Endogenous hormones as a major factor in human cancer. Cancer Res (1982), 42: 3232

    PubMed  CAS  Google Scholar 

  • Kvale G, Heuch I, Nilssen S et al. Reproductive factors and risk of ovarian cancer: A prospective study. Int J Cancer (1989), 42: 246

    Article  Google Scholar 

  • Lynch HT et al. Familial ovarian carcinoma. Am J Med (1986), 81: 1073

    Article  PubMed  CAS  Google Scholar 

  • Lynch HT et al. Hereditary carcinoma of the ovary and associated cancers: A study of two families. Gynecol Oncol (1990), 36: 48

    Article  PubMed  CAS  Google Scholar 

  • McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med (1996), 334: 1–6

    Article  PubMed  CAS  Google Scholar 

  • Petru E, Lahousen M, Tamussino K, Pickel H, Stranzel H, Stettner H, Winter R. Lymphadenectomy in Stage I ovarian cancer. Am J Ostet Gynecol (1994), 170: 656–662

    CAS  Google Scholar 

  • Seidman JD, Kurman RJ. Subclassification of serious borderline tumors of the ovary into benign and malignant types. A clinicopathological study of 65 advanced stage cases. Am J Surg Pathol (1996), 20: 1331–1345

    Article  PubMed  CAS  Google Scholar 

  • Seidman JD, Norris HJ, Griffin JL et al. DNA Flow Cytometric Analysis of Serous Ovarian Tumors of Low Malignant Potential. Cancer (1993), 71: 3947–3951

    Article  PubMed  CAS  Google Scholar 

  • Tavassoli FA. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol (1988), 1: 407–414

    PubMed  CAS  Google Scholar 

  • Wu ML, Whittemore AS et al. Personal and environmental characteristics related to epithelial ovarian cancer. Am J Epidemiol (1988), 128: 1216

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Salzer, H., Denison, U., Breitenecker, G., Lax, S., Kapp, K. (1999). Ovarialkarzinom. In: Smola, M.G. (eds) Manual der Chirurgischen Krebstherapie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6427-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6427-3_18

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82989-9

  • Online ISBN: 978-3-7091-6427-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics